{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:31:06Z","timestamp":1787776266786,"version":"build-2784847793"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"37","license":[{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,5]]},"DOI":"10.1093\/eurheartj\/ehae490","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T12:59:30Z","timestamp":1724677170000},"page":"3801-3803","source":"Crossref","is-referenced-by-count":2,"title":["Intravenous iron therapy in heart failure with preserved ejection fraction: how far have we walked?"],"prefix":"10.1093","volume":"45","author":[{"given":"Veraprapas","family":"Kittipibul","sequence":"first","affiliation":[{"name":"Duke Clinical Research Institute , Durham, NC ,","place":["USA"]},{"name":"Division of Cardiology, Department of Medicine, Duke University Medical Center , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3222-1719","authenticated-orcid":false,"given":"Robert J","family":"Mentz","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute , Durham, NC ,","place":["USA"]},{"name":"Division of Cardiology, Department of Medicine, Duke University Medical Center , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,8,26]]},"reference":[{"key":"2024100709442445200_ehae490-B1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/eurheartj\/ehac569","article-title":"Iron deficiency and cardiovascular disease","volume":"44","author":"Savarese","year":"2023","journal-title":"Eur Heart J"},{"key":"2024100709442445200_ehae490-B2","doi-asserted-by":"publisher","first-page":"e001012","DOI":"10.1136\/openhrt-2019-001012","article-title":"Iron deficiency in heart failure with preserved ejection fraction: a systematic review and meta-analysis","volume":"6","author":"Beale","year":"2019","journal-title":"Open Heart"},{"key":"2024100709442445200_ehae490-B3","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"2024100709442445200_ehae490-B4","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"key":"2024100709442445200_ehae490-B5","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1093\/eurheartj\/ehae479","article-title":"Ferric carboxymaltose and exercise capacity in heart failure with preserved ejection fraction and iron deficiency: the FAIR-HFpEF trial","volume":"45","author":"von Haehling","year":"2024","journal-title":"Eur Heart J"},{"key":"2024100709442445200_ehae490-B6","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.jchf.2018.03.017","article-title":"Validation of exercise capacity as a surrogate endpoint in exercise-based rehabilitation for heart failure: a meta-analysis of randomized controlled trials","volume":"6","author":"Ciani","year":"2018","journal-title":"JACC Heart Fail"},{"key":"2024100709442445200_ehae490-B7","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/eurheartj\/ehaa943","article-title":"Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes","volume":"42","author":"Abraham","year":"2021","journal-title":"Eur Heart J"},{"key":"2024100709442445200_ehae490-B8","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1038\/s41591-021-01536-x","article-title":"The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial","volume":"27","author":"Nassif","year":"2021","journal-title":"Nat Med"},{"key":"2024100709442445200_ehae490-B9","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1161\/circulationaha.123.065061","article-title":"Effect of dapagliflozin versus placebo on symptoms and 6-minute walk distance in patients with heart failure: the DETERMINE randomized clinical trials","volume":"149","author":"McMurray","year":"2024","journal-title":"Circulation"},{"key":"2024100709442445200_ehae490-B10","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"key":"2024100709442445200_ehae490-B11","doi-asserted-by":"publisher","DOI":"10.1177\/1753944719870084","article-title":"6-minute walking test: a useful tool in the management of heart failure patients","volume":"13","author":"Giannitsi","year":"2019","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"2024100709442445200_ehae490-B12","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.jchf.2022.09.012","article-title":"Functional and symptomatic clinical trial endpoints: the HFC-ARC Scientific Expert Panel","volume":"10","author":"Psotka","year":"2022","journal-title":"JACC Heart Fail"},{"key":"2024100709442445200_ehae490-B13","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1056\/NEJMoa2304968","article-title":"Ferric carboxymaltose in heart failure with iron deficiency","volume":"389","author":"Mentz","year":"2023","journal-title":"N Engl J Med"},{"key":"2024100709442445200_ehae490-B14","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.cardfail.2022.10.423","article-title":"Minimal clinically important differences in 6-minute walk test in patients with HFrEF and iron deficiency","volume":"29","author":"Khan","year":"2023","journal-title":"J Card Fail"},{"key":"2024100709442445200_ehae490-B15","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1001\/jamacardio.2016.1161","article-title":"Prevalence and outcomes of anemia and hematinic deficiencies in patients with chronic heart failure","volume":"1","author":"Cleland","year":"2016","journal-title":"JAMA Cardiol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/45\/37\/3801\/59616464\/ehae490.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/45\/37\/3801\/59616464\/ehae490.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T09:44:28Z","timestamp":1728294268000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/45\/37\/3801\/7741589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,26]]},"references-count":15,"journal-issue":{"issue":"37","published-online":{"date-parts":[[2024,8,26]]},"published-print":{"date-parts":[[2024,10,5]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehae490","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10,1]]},"published":{"date-parts":[[2024,8,26]]}}}